ID: ALA4537967

Max Phase: Preclinical

Molecular Formula: C19H19FN2

Molecular Weight: 294.37

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cc(-c2cnc3ccn(CC4CCC4)c3c2)ccc1F

Standard InChI:  InChI=1S/C19H19FN2/c1-13-9-15(5-6-17(13)20)16-10-19-18(21-11-16)7-8-22(19)12-14-3-2-4-14/h5-11,14H,2-4,12H2,1H3

Standard InChI Key:  MTXPFYDPXWYSJL-UHFFFAOYSA-N

Associated Targets(Human)

Glutamate NMDA receptor; GRIN1/GRIN2B 726 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 1A2 26471 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 2C19 29246 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 2C9 32119 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HERG 29587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Glutamate [NMDA] receptor subunit epsilon 2 915 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 294.37Molecular Weight (Monoisotopic): 294.1532AlogP: 4.95#Rotatable Bonds: 3
Polar Surface Area: 17.82Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.30CX LogP: 4.99CX LogD: 4.99
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.67Np Likeness Score: -1.51

References

1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA..  (2019)  1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators.,  10  (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542]

Source